Mantang F. Qiu

Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Harnessing the microbiome: a new frontier in lung cancer immunotherapy.

Harnessing the microbiome: a new frontier in lung cancer immunotherapy.

Journal: Cancer biology & medicine

Published: July 21, 2026

Non-destructive extraction and characterization of human pulmonary microplastics and the associated endocrine disrupting chemicals.

Non-destructive extraction and characterization of human pulmonary microplastics and the associated endocrine disrupting chemicals.

Journal: Environmental pollution (Barking, Essex : 1987)

Published: April 16, 2026

Circular RNA-based therapeutic vaccine elicits potent antigen-specific antitumor immunity and remodels tumor microenvironment in lung cancer.

Circular RNA-based therapeutic vaccine elicits potent antigen-specific antitumor immunity and remodels tumor microenvironment in lung cancer.

Journal: Cancer letters

Published: April 15, 2026

Locus-Specific Human Endogenous Retrovirus ERVK18 Expression Indicates an Inflamed Microenvironment and Favorable Immunotherapy Outcome in Small Cell Lung Cancer.

Locus-Specific Human Endogenous Retrovirus ERVK18 Expression Indicates an Inflamed Microenvironment and Favorable Immunotherapy Outcome in Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 02, 2025

Engineering lipid nanoparticle-stabilized emulsions for spatiotemporal mRNA delivery and enhanced T cell immunity.

Engineering lipid nanoparticle-stabilized emulsions for spatiotemporal mRNA delivery and enhanced T cell immunity.

Journal: Cell reports. Medicine

Published: June 22, 2025

Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer.

Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer.

Journal: Experimental hematology & oncology

Published: December 04, 2024

Amplification of Extrachromosomal MYC Paralogs Shapes Immunosuppressive Tumor Microenvironment in Small Cell Lung Cancer.

Amplification of Extrachromosomal MYC Paralogs Shapes Immunosuppressive Tumor Microenvironment in Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 19, 2024

Evaluation of clinical and safety outcomes of cancer vaccines in patients with advanced non-small cell lung cancer after first-line therapy: a systematic review and meta-analysis.

Evaluation of clinical and safety outcomes of cancer vaccines in patients with advanced non-small cell lung cancer after first-line therapy: a systematic review and meta-analysis.

Journal: EClinicalMedicine

Published: September 24, 2024

Development and validation of the systemic nutrition/inflammation index for improving perioperative management of non-small cell lung cancer.

Development and validation of the systemic nutrition/inflammation index for improving perioperative management of non-small cell lung cancer.

Journal: BMC medicine

Published: August 27, 2024

Synthetic circRNA therapeutics: innovations, strategies, and future horizons.

Synthetic circRNA therapeutics: innovations, strategies, and future horizons.

Journal: MedComm

Published: May 21, 2024

Restoring expression of tumour suppressor PTEN by engineered circular RNA-enhanced Osimertinib sensitivity in non-small cell lung cancer.

Restoring expression of tumour suppressor PTEN by engineered circular RNA-enhanced Osimertinib sensitivity in non-small cell lung cancer.

Journal: Clinical and translational medicine

Published: May 10, 2024

N1-methylpseudouridine modification level correlates with protein expression, immunogenicity, and stability of mRNA.

N1-methylpseudouridine modification level correlates with protein expression, immunogenicity, and stability of mRNA.

Journal: MedComm

Published: April 24, 2024

Showing 1-12 of 93

Last Updated: 09/26/2026